⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Methylhistamine SCHEMBL29291045 | 0.98 | HRH4 (0.39) | — | |
| 2-Methylhistamine SCHEMBL2369590 | 0.98 | TDP1 (0.41) | — | |
| SCHEMBL1534264 | 0.88 | HRH4 (0.37) | — | |
| SCHEMBL23846225 | 0.86 | HRH3 (0.39) | — | |
| SCHEMBL3403486 | 0.82 | — | — | |
| SCHEMBL30586310 | 0.82 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL82665 | 0.80 | — | — | |
| SCHEMBL6105714 | 0.78 | — | — | |
| SCHEMBL8611446 | 0.78 | — | — | |
| SCHEMBL7170380 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114479-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | INSTITUTE OF PROCESS ENGINEERING , CHINESE ACADEMY OF SCIENCES (CN) | 2025-04-10 | — | — | US | claimed |
| US-20240277668-A1 | HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS | TSP THERAPEUTICS INC. | 2024-08-22 | — | — | US | claimed |
| EP-4376835-A1 | HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS | TSP Therapeutics Inc. (US) | 2024-06-05 | — | — | EP | claimed |
| US-20240165082-A1 | ORALLY ADMINISTERED COMPOSITIONS FOR CANCER TREATMENT | TSP THERAPEUTICS INC. | 2024-05-23 | — | — | US | claimed |
| EP-4340838-A1 | ORALLY ADMINISTERED COMPOSITIONS FOR CANCER TREATMENT | Paz, Alberto (US) | 2024-03-27 | — | — | EP | claimed |
| CN-117479964-A | Tissue-selective single-component mRNA delivery vector and delivery system | 中国科学院过程工程研究所 | 2024-01-30 | — | — | CN | claimed |
| WO-2023009261-A1 | HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS | PAZ ALBERTO (US) | 2023-02-02 | — | — | WO | claimed |
| CN-113480958-B | Special dual-curing epoxy adhesive for automobile camera AA (acrylic acid) manufacturing process, preparation method and application | 顺德职业技术学院 | 2022-12-09 | — | — | CN | claimed |
| WO-2022245650-A1 | ORALLY ADMINISTERED COMPOSITIONS FOR CANCER TREATMENT | PAZ ALBERTO (US) | 2022-11-24 | — | — | WO | claimed |
| EP-3303441-B1 | FAST CURE EPOXY RESIN COMPOSITIONS | CYTEC INDUSTRIAL MAT DERBY LIMITED (GB) | 2021-11-10 | — | — | EP | claimed |
| WO-2008043356-A1 | ADHESION PROMOTER LAYER FOR BONDING A HOLOGRAPHIC DATA STORAGE MEDIUM TO A SUBSTRATE | BUNDESDRUCKEREI GMBH (DE) | 2008-04-17 | — | — | WO | claimed |
| US-20070086981-A1 | Delivery peptides, their constructs with active agents and use | ORTHOGEN AG (DE) | 2007-04-19 | — | — | US | claimed |
| EP-1694696-A1 | DELIVERY PEPTIDES ,THEIR CONSTRUCTS WITH ACTIVE AGENTS AND USE | ORTHOGEN Aktiengesellschaft (DE) | 2006-08-30 | — | — | EP | claimed |
| EP-0925356-B1 | NEW ANTIGEN PRESENTING CELLS, A PROCESS FOR PREPARING THE SAME AND THEIR USE AS CELLULAR VACCINES | IDM IMMUNO DESIGNED MOLECULES (FR) | 2005-12-28 | — | — | EP | claimed |
| WO-2005054279-A1 | DELIVERY PEPTIDES, THEIR CONSTRUCTS WITH ACTIVE AGENTS AND USE | ORTHOGEN AG (DE) | 2005-06-16 | — | — | WO | claimed |
| EP-1135481-A1 | NEW OLIGOMERIC CONJUGATES LIABLE TO TRANSFER BIOLOGICAL MOLECULES INTO CELLS | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 2001-09-26 | — | — | EP | claimed |
| WO-2000032764-A1 | NEW OLIGOMERIC CONJUGATES LIABLE TO TRANSFER BIOLOGICAL MOLECULES INTO CELLS | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 2000-06-08 | — | — | WO | claimed |
| EP-0858725-A1 | MULTILAYER PRINTED CIRCUIT BOARD AND PROCESS FOR PRODUCING THE SAME | Sumitomo Bakelite Company Limited (JP) | 1998-08-19 | — | — | EP | claimed |
| WO-1997016948-A1 | MULTILAYER PRINTED CIRCUIT BOARD AND PROCESS FOR PRODUCING THE SAME | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 1997-05-09 | — | — | WO | claimed |
| US-4474876-A | Flow cytometric analysis of histamine receptors | TRUSTEES OF BOSTON UNIVERSITY (US) | 1984-10-02 | — | — | US | claimed |